Severe air pollution forced the Delhi government on Monday to suspend physical classes for younger students, directing ...

EMA committee recommends approval of an expanded indication for Merck’s Winrevair in adults with pulmonary arterial hypertension: Rahway, New Jersey Monday, December 15, 2025, 1 ...

Nuvalent Inc. (NASDAQ:NUVL) is one of the best 52-week high stocks to buy right now. On November 24, Truist Securities ...

MAIA Biotechnology (NYSE American: MAIA) - The treatment paradigm for advanced non-small cell lung cancer (NSCLC) is ...

Catumaxomab Is the Only Approved Drug Therapy for Malignant Ascites, a Rare and Debilitating Complication of Advanced-stage CancerLaunch Offers Prolonged Puncture-free Survival and Delayed ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

A year of new treatments, new technologies, new ways to stay safe during disasters and new insights on the mysteries of the ...

Financing includes participation from leading institutional investors including Janus Henderson Investors, Brahma Capital, Biotrack Capital, Cormorant Asset Management, OrbiMed, Plaisance Capital ...

RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in ...

Bangladesh’s under-21 hockey heroes step back onto home soil, carrying a surge of praise, promise and renewed belief.

Proceeds to further advance clinical development of BH-30643, a first-in-class, macrocyclic, CNS-active, mutant-selective OMNI-EGFRTM inhibitor ...